Dr. Eric James Kezirian, MD

Dr. Kezirian practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Kezirian's NPI, 1982669701, was assigned on April 18, 2006. Dr. Kezirian graduated from Perelman School of Medicine - Philadelphia in 1997. Dr. Kezirian holds California license A83825.

Dr. Kezirian's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Kezirian's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Kezirian is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Dr. Kezirian to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kezirian practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Kezirian's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Kezirian is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Kezirian is licensed in California.

Dmand AI lists upper respiratory infection (URI) among the conditions Dr. Kezirian treats.

CMS data shows 215 Medicare services from Dr. Kezirian across 7 procedure codes in 2024, for 99 Medicare patients. Medicare paid $28,331 for them.

CMS counts 99 Medicare patients who saw Dr. Kezirian in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kezirian's median patient age at 54, with 25% women.

In 2024, Dr. Kezirian wrote 83 Medicare Part D claims for 28 patients. 100% of them were for generic drugs. CMS names the drug for 71 of them, across 4 drugs with 11 or more claims each, at $499 in total drug cost.

Dr. Kezirian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kezirian as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 127 papers to Dr. Kezirian, published from 2009 to 2025. 2018 was the busiest year, with 8. The most frequent topics are Sleep Apnea, Obstructive, Endoscopy and Polysomnography. Dr. Kezirian has published most often in Otolaryngol Head Neck Surg. Dr. Kezirian's most frequent co-authors are Andrew N. Goldberg, MD, Atul Malhotra, MD and Colin T. Huntley, MD.

Dmand AI links Dr. Kezirian to 7 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Sleep Apnea, Obstructive, Sleep Apnea Syndromes and Sleepiness. University of California, Los Angeles sponsors the most, 2.

CMS Open Payments shows 3 general payments to Dr. Kezirian from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Inspire Medical Systems, Inc. paid the most, $84.

Dmand AI lists 9 awards for Dr. Kezirian, most recently CMS Stage 1 EHR in 2012.

Dr. Kezirian graduated from Perelman School of Medicine - Philadelphia in 1997. Dr. Kezirian is a member of NHS, AASM and ACS.

Dr. Kezirian is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.